Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

ClinicalTrials.gov ID: NCT00583986

Public ClinicalTrials.gov record NCT00583986. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 20, 2026, 1:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Determine the Reliability of a Top Mount Actuation Indicator When Used With Levalbuterol Tartrate HFA MDI in Adult and Pediatric Subjects With Asthma or Chronic Obstructive Pulmonary Disease

Study identification

NCT ID
NCT00583986
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

  • Levalbuterol HFA MDI with top mounted actuation indicator Drug

Drug

Eligibility (public fields only)

Age range
4 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2005
Primary completion
Dec 31, 2005
Completion
Feb 28, 2006
Last update posted
Feb 21, 2012

2005 – 2006

United States locations

U.S. sites
26
U.S. states
13
U.S. cities
26
Facility City State ZIP Site status
Not listed Encinatas California 92024
Not listed Huntington Beach California 92647
Not listed Mesa California 92626
Not listed Orange County California 92868
Not listed Riverside California 92506
Not listed San Diego California 92120
Not listed San Jose California 95128
Not listed Viejo California 92691
Not listed Walnut Creek California 94596
Not listed Tamarac Florida 33321
Not listed Russells Mills Massachusetts 02747
Not listed Commack New York 11725
Not listed Rochester New York 14618
Not listed Elizabeth City North Carolina 27909
Not listed Oklahoma City Oklahoma 73120
Not listed Medford Oregon 97504
Not listed Portland Oregon 97213
Not listed Philadelphia Pennsylvania 19115
Not listed Simpsonville South Carolina 29681
Not listed Chattanooga Tennessee 37421
Not listed Austin Texas 78750
Not listed Braunfels Texas 78130
Not listed San Antonio Texas 78229
Not listed Burke Virginia 22015
Not listed Richmond Virginia 23225
Not listed Morgantown West Virginia 26505

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00583986, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 21, 2012 · Synced Jul 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00583986 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →